CorMedix Inc. short interest in 2023
In 2023, CorMedix Inc.'s disclosed short interest ran from 3.98% of shares outstanding on 13 Jan 2023 to 12.94% on 29 Dec 2023, a change of +8.96 percentage points. The year's high was 14.28% on 30 Nov 2023 and its low 3.89% on 28 Feb 2023, averaging 7.89% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.07 days on 29 Dec 2023. Full history: CorMedix Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 3.98% (13 Jan 2023)
- End of year
- 12.94% (29 Dec 2023)
- Change
- +8.96 pp
- High
- 14.28% (30 Nov 2023)
- Low
- 3.89% (28 Feb 2023)
- Average
- 7.89%
- Highest days to cover
- 14.07 (29 Dec 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 3.98% | 6.32 | |
| 31 Jan 2023 | 4.02% | 6.39 | |
| 15 Feb 2023 | 3.90% | 8.45 | |
| 28 Feb 2023 | 3.89% | 7.90 | |
| 15 Mar 2023 | 4.04% | 6.98 | |
| 31 Mar 2023 | 4.47% | 8.84 | 10-K filed, results (8-K) |
| 14 Apr 2023 | 4.62% | 5.39 | |
| 28 Apr 2023 | 4.98% | 6.62 | |
| 15 May 2023 | 4.89% | 8.18 | 10-Q filed, results (8-K) |
| 31 May 2023 | 5.88% | 6.04 | |
| 15 Jun 2023 | 6.82% | 7.28 | |
| 30 Jun 2023 | 11.74% | 2.87 | |
| 14 Jul 2023 | 11.72% | 5.33 | |
| 31 Jul 2023 | 9.80% | 7.05 | |
| 15 Aug 2023 | 7.35% | 8.53 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 7.37% | 11.41 | |
| 15 Sep 2023 | 8.51% | 7.44 | |
| 29 Sep 2023 | 9.05% | 11.19 | |
| 13 Oct 2023 | 9.33% | 12.56 | |
| 31 Oct 2023 | 10.39% | 11.86 | |
| 15 Nov 2023 | 12.15% | 3.45 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 14.28% | 6.78 | |
| 15 Dec 2023 | 13.13% | 12.00 | |
| 29 Dec 2023 | 12.94% | 14.07 |
See also: CorMedix Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.